MUROMONAB-CD3
UNII JGA39ICE2V

Substance Identification & Data

This profile provides standardized clinical and technical data for Muromonab-cd3, uniquely identified by the FDA Unique Ingredient Identifier (UNII) JGA39ICE2V.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 140608-64-6 and the RxNorm Concept ID (RxCUI) 42405. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

JGA39ICE2V

CAS Registry Number

140608-64-6

RxNorm Concept ID

42405

Detailed Substance Profile

Preferred Name

MUROMONAB-CD3

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C1321

National Cancer Institute reference terminology for clinical and research data.

INN ID

6281

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

Y-93

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Muromonab-cd3. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

MUROMONAB-CD3

Common Names & Synonyms

ANTICD3

MUROMOMAB

MUROMONAB

MUROMONAB CD3

MUROMONAB CD3 [MI]

MUROMONAB-CD3 [INN]

MUROMONAB-CD3 [JAN]

MUROMONAB-CD3 [MART.]

MUROMONAB-CD3 [USAN]

MUROMONAB-CD3 [VANDF]

MUROMONAB-CD3 [WHO-DD]

PURIFIED IGG2A IMMUNOGLOBULIN MANUFACTURED INVOLVING FUSION OF MOUSE MYELOMA CELLS TO LYMPHOCYTES FROM IMMUNIZED ANIMALS TO PRODUCE A HYBRIDOMA WHICH SECRETES ANTIGEN-SPECIFIC ANTIBODIES TO THE T3 ANTIGEN OF HUMAN T-LYMPHOCYTES